1 Min Read
Oct 5 (Reuters) - Alembic Pharmaceuticals Ltd
* Formulation facility located at Panelav has received EIR from US FDA for the inspection carried out by them in March, 2016. Source text: bit.ly/2cRosD5 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.